Healthcare costs keep rising, and the question everyone in this industry is asking is why, and what comes next. On the latest episode of Next in Health, I sat down with the team to dig into into PwC's Behind the Numbers 2027 report.
https://t.co/e8EQih2kYo
Digital health is entering a new era of regulation, from AI oversight to real‑world data and rapid market entry. See how medtech leaders can respond and build smarter evidence strategies. Learn more: https://t.co/OMPZm9WgeL
PwC joins Unrivaled Basketball as an Official League Partner in a new multiyear strategic partnership geared towards league growth. PwC will leverage its unmatched expertise to provide strategic services, helping Unrivaled's operational scale and long-term vision.
🏀 Hey @PingryAthletics fans! 🏀
Vote now for Charlotte Hunzinger (@CharlotteHunz28) to win the JSZ Week 2 Girls Basketball Game Ball for her performance (35 points, 13 rebounds) against Watchung Hills.
🗳️ Cast your votes HERE ⬇️
https://t.co/JbXdBOxWkQ
RHTP unlocks $50B for rural health: care hubs, mobile clinics, workforce pipelines, data platforms, and financial stabilization. Position your org for 2026. Learn how in the report: https://t.co/Pu4lI2IeKB
Trump signs the One Big Beautiful Bill Act, reshaping Medicaid and ACA policy. $1T in projected savings through 2034. See what it means for healthcare.
https://t.co/qRBZQAeuFg
My good friend and colleague Phil Scalfani brings light to how MFN will likely play out and how it may reshape our Industry and how to prepare for potential disruption. Listen here:
https://t.co/piJePrl419
Our refreshed look captures the momentum we’re building at PwC— and our commitment to helping clients drive their businesses to the leading edge. Learn more. https://t.co/3PEQ2ln63m
On May 12th, the Trump administration signed an Executive Order (EO) to implement a “Most Favored Nation” (MFN) drug pricing policy. There is a bit to unpack as it relates to the EO and how it will work / play out and this will become legislation. https://t.co/qaW6s5b5gf
PwC is proud to be the Official Consulting Partner of @F1, helping drive operational excellence with one of the one of the most advanced and globally dynamic sports in the world. Learn more. https://t.co/1JlDUb63dv
In our latest edition of this series, we evaluate the impacts of recent tariff policies and provide strategic insights for pharma, life science and medtech leaders to effectively assess and manage potential tariff exposure. https://t.co/izDiH9dcUl
In our latest blog, PwC’s Francis Ruffy and Conga’s Tom Cowen, dig into MedTech contracting, revealing actionable strategies to transform negotiation and execution into a seamless, effective process.
https://t.co/k241kDnJrq
Always great to speak with my buddy Greg Rotz, PwC’s Pharma & Life Sciences leader as he shares the 2025 pharma outlook—from a $400B patent cliff to rising competition. How can companies stay ahead? Listen now:
https://t.co/7x9DbShbbn
Our new report highlights President Trump's healthcare agenda, emphasizing how these initiatives can reshape the healthcare landscape, influence market dynamics and impact budget allocations. https://t.co/VzxUKyjpOZ
So proud of our team who work tirelessesly with client obsession, knowing that what we do drives our clients to do what they do best - save lives
PwC is named a Leader in the IDC MarketScape: Worldwide Medical Devices Consulting Services 2024–2025.
https://t.co/rrGAsvU2bH
As President Trump begins his second term, companies are bracing for change. Learn more about the new administration’s policy shifts and how you can prepare your business to navigate effectively. https://t.co/XI62bUGOw7
#Pharma and #medtech deals are expected to grow next year due in part to GLP-1 opportunities, interest rate cuts, and potential changes in the perspectives of anti-trust regulators. Read more in PwC US Pharma and Life Sciences US Deals 2025 outlook: https://t.co/dTrHTto1lZ
Join our panel of operations specialists on April 16 to learn why significant business outcomes are still difficult to achieve – and what you can do. Register: https://t.co/9MZNFtRCiM